封面
市場調查報告書
商品編碼
1982458

全球冠狀動脈繞道手術手術市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Coronary Artery Bypass Grafts Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 136 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

冠狀動脈繞道手術手術市場預計將從 2025 年的 123.7 億美元成長到 2034 年的 292.6 億美元,2026 年至 2034 年的複合年成長率為 10.04%。

隨著全球心血管疾病發生率的不斷上升,全球冠狀動脈繞道手術手術市場也不斷擴張。冠狀動脈繞道手術手術是一種透過疏通阻塞或狹窄的動脈來改善心臟供血的醫療手術。對於患有嚴重冠狀動脈疾病的患者,通常會建議進行此項治療方法,以降低心肌梗塞的風險並改善整體心臟功能。

推動該市場成長的因素有很多。人口老化以及肥胖、高膽固醇等文明病導致心臟病發病率不斷上升。外科和內科技術的進步提高了搭橋手術的安全性和有效性。此外,診斷能力的提升使得早期發現心血管疾病成為可能。

隨著醫療衛生系統持續應對全球心血管疾病的挑戰,冠狀動脈繞道手術手術市場預計將會成長。手術材料和技術的創新將改善患者的治療效果和復原時間。醫療保健投入的增加以及人們對心臟健康意識的提高將進一步推動市場擴張。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球冠狀動脈繞道手術手術市場:依手術方式分類

  • 市場分析、洞察與預測
  • 非泵送
  • 泵浦上
  • 微創直接方法

第5章:全球冠狀動脈繞道手術手術市場:依手術方式分類

  • 市場分析、洞察與預測
  • 單身的
  • 雙倍的
  • 三倍
  • 四倍

第6章:全球冠狀動脈繞道手術手術市場:依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 心臟病中心
  • 其他

第7章:全球冠狀動脈繞道手術手術市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic Plc
    • Terumo Corporation
    • Guidant Group
    • MAQUET Holding BV & Co.KG
    • Novadaq Technologies Inc
    • KARL STORZ GmbH & Co. KG
    • Edwards Lifesciences Corporation
    • Genesee Biomedical Inc
    • Sorin Group
簡介目錄
Product Code: VMR11211909

The Coronary Artery Bypass Grafts Market size is expected to reach USD 29.26 Billion in 2034 from USD 12.37 Billion (2025) growing at a CAGR of 10.04% during 2026-2034.

The global coronary artery bypass grafts market has grown due to the increasing prevalence of cardiovascular diseases worldwide. Coronary artery bypass graft surgery is a medical procedure used to improve blood flow to the heart by bypassing blocked or narrowed arteries. This treatment is often recommended for patients with severe coronary artery disease to reduce the risk of heart attacks and improve overall heart function.

Several factors are driving the growth of this market. Aging populations and lifestyle-related health conditions such as obesity and high cholesterol are increasing the incidence of heart disease. Advances in surgical techniques and medical technologies have improved the safety and effectiveness of bypass procedures. Additionally, improved diagnostic capabilities allow earlier detection of cardiovascular problems.

In the future, the coronary artery bypass grafts market is expected to grow as healthcare systems continue to address the global burden of cardiovascular diseases. Innovations in surgical materials and techniques will improve patient outcomes and recovery times. Increasing healthcare investments and growing awareness of heart health will further support market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Method

  • Off-Pump
  • On-Pump
  • Minimally Invasive Direct

By Surgical Procedure

  • Single CABG Surgery
  • Double CABG Surgery
  • Triple CABG Surgery
  • Quadruple CABG Surgery

By End Use

  • Hospitals
  • Cardiology Centres
  • Others

COMPANIES PROFILED

  • Medtronic plc, Terumo Corporation, Guidant Group, MAQUET Holding BV CoKG, Novadaq Technologies Inc, KARL STORZ GmbH Co KG, Edwards Lifesciences Corporation, Genesee Biomedical Inc, Sorin Group
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET: BY METHOD 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Method
  • 4.2. Off-Pump Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. On-Pump Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Minimally Invasive Direct Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET: BY SURGICAL PROCEDURE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Surgical Procedure
  • 5.2. Single CABG Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Double CABG Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Triple CABG Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Quadruple CABG Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cardiology Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Method
    • 7.2.2 By Surgical Procedure
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Method
    • 7.3.2 By Surgical Procedure
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Method
    • 7.4.2 By Surgical Procedure
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Method
    • 7.5.2 By Surgical Procedure
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Method
    • 7.6.2 By Surgical Procedure
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CORONARY ARTERY BYPASS GRAFTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medtronic Plc
    • 9.2.2 Terumo Corporation
    • 9.2.3 Guidant Group
    • 9.2.4 MAQUET Holding B.V. & Co.KG
    • 9.2.5 Novadaq Technologies Inc
    • 9.2.6 KARL STORZ GmbH & Co. KG
    • 9.2.7 Edwards Lifesciences Corporation
    • 9.2.8 Genesee Biomedical Inc
    • 9.2.9 Sorin Group